[
    [
        {
            "time": "",
            "original_text": "机构买入评级大幅扩围，64股看涨逾70%",
            "features": {
                "keywords": [
                    "机构",
                    "买入评级",
                    "扩围",
                    "看涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "机构买入评级大幅扩围，64股看涨逾70%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：药明康德、迈瑞医疗等市值底部已现 无需恐慌",
            "features": {
                "keywords": [
                    "医药生物",
                    "药明康德",
                    "迈瑞医疗",
                    "市值底部"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：药明康德、迈瑞医疗等市值底部已现 无需恐慌",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "8月备受基金公司关注的三个行业：医药医疗、电气设备、工业机械",
            "features": {
                "keywords": [
                    "8月",
                    "基金公司",
                    "医药医疗",
                    "电气设备",
                    "工业机械"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "电气设备",
                    "工业机械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "8月备受基金公司关注的三个行业：医药医疗、电气设备、工业机械",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国金证券首予华东医药买入评级：医药工业品质技术升级，医美全球逐步开花，目标价45.1元",
            "features": {
                "keywords": [
                    "国金证券",
                    "华东医药",
                    "买入评级",
                    "医药工业",
                    "品质技术升级",
                    "医美",
                    "目标价"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国金证券首予华东医药买入评级：医药工业品质技术升级，医美全球逐步开花，目标价45.1元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]